Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2011
MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinomaMeir Preis, Timothy B Gardner, Stuart R Gordon, et al.
Haematologica|February 12, 2026
ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot studyGil Fridberg, Odelia Amit, Yehonathan Sherf, et al.
The Journal of Clinical Investigation|March 19, 2010
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressorsXi Liu, Lorenzo F Sempere, Haoxu Ouyang, et al.
Blood Cells, Molecules & Diseases|June 7, 2011
Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivoMichael S Boosalis, Serguei A Castaneda, Marie Trudel, et al.
Palliative Medicine|March 25, 2021
Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapyLiza Barki-Harrington, Orna Baron-Epel, Adir Shaulov, et al.
Cancer Immunology Research|May 16, 2019
Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentJie Deng, Jiannan Li, Aurelien Sarde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid TumorsMaria Vieito, Victor Moreno, Anna Spreafico, et al.
Leukemia Research|September 30, 2023
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromesTamanna Haque, Felix López Cadenas, Blanca Xicoy, et al.
Transplantation and Cellular Therapy|October 13, 2024
Addition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion-A Phase 2, Prospective Interventional StudyRon Ram, Odelia Amit, Chava Perry, et al.
Blood Advances|September 18, 2023
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphomaLoretta J Nastoupil, Georg Hess, Miguel A Pavlovsky, et al.
Pageof 7